Buckingham Strategic Partners Abbott Laboratories Transaction History

Buckingham Strategic Partners

$4.37 Billion
Q3 2024

A detailed history of Buckingham Strategic Partners transactions in Abbott Laboratories stock. As of the latest transaction made, Buckingham Strategic Partners holds 25,056 shares of ABT stock, worth $2.83 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

25,056

Previous 22,958 9.14%

Holding current value

$2.83 Million

Previous $2.39 Million 19.75%

% of portfolio

0.07%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $209,946 - $247,836	2,098 Added 9.14%	25,056 $2.86 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $239,435 - $267,269	-2,377 Reduced 9.38%	22,958 $2.39 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $2.14 Million - $2.36 Million	19,525 Added 336.06%	25,335 $2.88 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $1.17 Million - $1.43 Million	-12,967 Reduced 69.06%	5,810 $639,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.24 Million - $1.49 Million	13,011 Added 225.65%	18,777 $1.82 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $152,077 - $169,445	1,509 Added 35.45%	5,766 $628,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $147,324 - $173,409	1,521 Added 55.59%	4,257 $431,000
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $1.19 Million - $1.4 Million	-12,560 Reduced 82.11%	2,736 $300,000
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $1.02 Million - $1.18 Million	10,522 Added 220.4%	15,296 $1.48 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $94,414 - $114,117	925 Added 24.03%	4,774 $519,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $438,862 - $535,164	3,849 New	3,849 $455,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Partners with notifications on news.

Account

Buckingham Strategic Partners Abbott Laboratories Transaction History